Header Logo

Jeffrey Bernhard

Concepts (87)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pruritus
15
2020
29
3.980
Why?
Dermatology
5
2023
69
1.150
Why?
Peripheral Nervous System Diseases
2
2020
27
0.800
Why?
Publishing
3
2008
89
0.710
Why?
Triamcinolone Acetonide
1
2020
13
0.700
Why?
Periodicals as Topic
3
2008
172
0.650
Why?
Emollients
1
2013
5
0.430
Why?
Histamine Antagonists
1
2013
5
0.430
Why?
Terminology as Topic
2
2015
138
0.340
Why?
Severity of Illness Index
2
2013
1448
0.320
Why?
Editorial Policies
2
2006
53
0.300
Why?
Bibliometrics
2
2008
27
0.300
Why?
Histamine
1
2005
27
0.260
Why?
Medical Records
1
2006
137
0.260
Why?
Ice
1
2005
5
0.250
Why?
Pruritus Ani
1
2005
1
0.250
Why?
Dermatitis, Seborrheic
1
2005
6
0.250
Why?
Regional Blood Flow
1
2005
107
0.250
Why?
Hot Temperature
1
2005
125
0.250
Why?
Humans
22
2023
59328
0.240
Why?
Diagnostic Errors
1
2005
98
0.230
Why?
Cervical Vertebrae
2
2013
100
0.220
Why?
Skin
1
2005
351
0.210
Why?
Spinal Diseases
1
2003
47
0.210
Why?
Antipruritics
2
2012
2
0.190
Why?
Injections, Intralesional
1
2020
12
0.180
Why?
Chronic Disease
4
2013
732
0.180
Why?
Nervous System Diseases
2
2015
95
0.170
Why?
History, Ancient
1
2015
11
0.120
Why?
Sunlight
1
2015
29
0.120
Why?
History, 19th Century
1
2015
42
0.120
Why?
Retrospective Studies
3
2020
5975
0.110
Why?
History, 20th Century
1
2015
226
0.110
Why?
Mianserin
1
2013
3
0.110
Why?
Cyclohexanecarboxylic Acids
1
2013
9
0.110
Why?
Antidepressive Agents, Tricyclic
1
2013
20
0.110
Why?
Excitatory Amino Acid Antagonists
1
2013
31
0.110
Why?
Amines
1
2013
30
0.110
Why?
Treatment Outcome
3
2020
5142
0.110
Why?
Receptors, Opioid, kappa
1
2012
3
0.100
Why?
gamma-Aminobutyric Acid
1
2013
79
0.100
Why?
Male
6
2013
27509
0.100
Why?
Behavior Therapy
1
2013
161
0.100
Why?
Arm
2
2013
38
0.090
Why?
Receptors, Opioid, mu
1
2010
15
0.090
Why?
Aminoquinolines
1
2009
15
0.090
Why?
Fluorouracil
1
2009
54
0.080
Why?
Carcinoma, Basal Cell
1
2009
61
0.080
Why?
Carcinoma, Squamous Cell
1
2009
233
0.070
Why?
Peer Review, Research
1
2008
46
0.070
Why?
Psychophysiologic Disorders
1
2007
7
0.070
Why?
Skin Pigmentation
1
2006
32
0.070
Why?
Skin Diseases
1
2007
74
0.060
Why?
Dermatitis, Atopic
1
2005
21
0.060
Why?
Cold Temperature
1
2005
51
0.060
Why?
Soaps
1
2005
6
0.060
Why?
Review Literature as Topic
1
2005
33
0.060
Why?
Decision Trees
1
2005
50
0.060
Why?
Female
5
2013
30827
0.060
Why?
Skin Neoplasms
1
2009
404
0.060
Why?
Middle Aged
3
2013
16238
0.060
Why?
Antineoplastic Agents
1
2009
643
0.060
Why?
Peer Review
1
2004
25
0.060
Why?
Uncertainty
1
2023
32
0.050
Why?
Biopsy
1
2005
373
0.050
Why?
Pain
1
2005
406
0.050
Why?
United States
2
2006
7494
0.050
Why?
Aged
3
2013
13293
0.050
Why?
Radiography
1
2003
505
0.050
Why?
Reproducibility of Results
1
2005
1549
0.050
Why?
Time Factors
1
2004
3567
0.030
Why?
Spinal Nerves
1
2013
5
0.030
Why?
Morphinans
1
2012
1
0.030
Why?
Butorphanol
1
2012
4
0.030
Why?
Spiro Compounds
1
2012
12
0.030
Why?
Metabolic Clearance Rate
1
2009
42
0.020
Why?
Administration, Topical
1
2009
52
0.020
Why?
Naloxone
1
2010
54
0.020
Why?
Drug Administration Schedule
1
2010
281
0.020
Why?
Naltrexone
1
2010
76
0.020
Why?
Administration, Oral
1
2010
345
0.020
Why?
Dose-Response Relationship, Drug
1
2010
810
0.020
Why?
Randomized Controlled Trials as Topic
1
2010
666
0.020
Why?
Adult
1
2003
15735
0.020
Why?
Follow-Up Studies
1
2010
2323
0.010
Why?
Risk Assessment
1
2010
1907
0.010
Why?
Animals
1
2012
19612
0.010
Why?
Bernhard's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (87)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_